ImmunityBio, Inc. (FRA:26CA)
Germany · Delayed Price · Currency is EUR 1.921
+0.100 (5.49%)
Last updated: Nov 28, 2025, 8:05 AM CET
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of €1.95 billion as of December 1, 2025. Its market cap has decreased by -40.06% in one year.
Market Cap
1.95B
Enterprise Value
2.47B
Revenue
70.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.92
Market Cap Chart
Since March 10, 2021, ImmunityBio's market cap has decreased from 12.47B to 1.95B, a decrease of -84.37%. That is a compound annual growth rate of -32.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 2.00B | 11.03% |
| Dec 31, 2024 | 1.81B | -40.46% |
| Dec 29, 2023 | 3.03B | 56.14% |
| Dec 30, 2022 | 1.94B | -8.68% |
| Dec 31, 2021 | 2.13B | -82.94% |
| Mar 10, 2021 | 12.47B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |